Skip to content

Clinical trials

Terminated Liver Diseases trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Liver Diseases Status: Terminated Country / region: United States Clear all

38 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20011
20053
20061
20072
20084
20102
20112
20121
20133
20141
20162
20172
20185
20212
20222
20232
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated38

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
University of Texas Southwestern Medical Center3
Boehringer Ingelheim2
Emory University2
Mayo Clinic2
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)2
Rutgers, The State University of New Jersey2
Abbott1
Argon Medical Devices1
Bausch Health Americas, Inc.1
Biogen1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Liver Diseases38
Fibrosis8
Hepatitis C6
Liver Cirrhosis6
Non-alcoholic Fatty Liver Disease6
Hepatitis5
Liver Neoplasms4
Carcinoma, Hepatocellular3
Fatty Liver3
Liver Failure3

Trials

Showing 1 to 25 of 38. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.